Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Submitted by
admin
on October 21, 2013 - 5:51pm
Source:
Yahoo
News Tags:
diabetes
Depomed
PDL Biopharma
Headline:
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Do Not Allow Advertisers to Use My Personal information
